Bloomberg Markets & Finance via Youtube

Nov.26 — AstraZeneca Plc is likely to conduct an additional global trial to assess the efficacy of its Covid-19 vaccine, according to Pascal Soriot, the company’s chief executive officer, after current studies raised questions over its level of protection. Suzi Ring reports on “Bloomberg Markets: European Close.”

READ ALSO  SE: YTL Corp.’s Yeoh on Coronavirus, M&A, Business Strategy